SCHEMBL845429

SCHEMBL845429

CN(C)[C@H]1C[C@@H](C(=O)Nc2ccc(/C=C/c3ccc(NC(=O)[C@@H]4C[C@H](N(C)C)CN4C(=O)Cc4ccccc4)cc3)cc2)N(C(=O)Cc2ccccc2)C1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CTSS P25774 1/20 0.44
CTSK P43235 1/20 0.44
HDAC8 Q9BY41 1/20 0.42
MCHR1 Q99705 3/20 0.41
MAOA P21397 1/20 0.41
MAOB P27338 1/20 0.41
CYP2D6 P10635 3/20 0.40
S1PR1 P21453 3/20 0.40
CYP3A4 P08684 2/20 0.40
NAMPT P43490 1/20 0.40
POLB P06746 1/20 0.39
BCHE P06276 3/20 0.39
ACHE P22303 3/20 0.39
KMT2A Q03164 2/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
ALDH1A1 P00352 1/20 0.38
GPR183 P32249 1/20 0.38
CYP2C9 P11712 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL873095 0.90 HDAC8 (0.38) CTSSCTSKHDAC8MCHR1MAOA
SCHEMBL845354 0.85 POLB (0.57) POLBKMT2ALMNANPSR1ALDH1A1
SCHEMBL846148 0.85 POLB (0.51) CTSSCTSKHDAC8CYP2D6S1PR1
SCHEMBL845778 0.82 CTSS (0.43) CTSSCTSKHDAC8CYP2D6S1PR1
SCHEMBL845439 0.81 ALDH1A1 (0.38) MCHR1MAOAMAOBNAMPTPOLB
SCHEMBL845370 0.80 PIK3CA (0.37) MCHR1NAMPTPOLBKMT2AMMP2
SCHEMBL845777 0.78 POLB (0.44) CTSSCTSKHDAC8CYP2D6S1PR1
SCHEMBL845226 0.78 ALDH1A1 (0.56) LMNAALDH1A1CYP2C9
SCHEMBL845205 0.78 ALDH1A1 (0.56) LMNAALDH1A1CYP2C9
SCHEMBL15116912 0.78 ALDH1A1 (0.56) LMNAALDH1A1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed